UK medical cannabis patients have been told that they’ll have access to a six-month stockpile of Bedrolite, following weeks of uncertainty in the wake of Bedrocan’s collapse.
The global cannabis industry barely had time to catch its breath over the Christmas break, following several seismic developments at the tail end of the year.
A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group of the cannabis industry’s leading voices for an unprecedented inaugural global summit.
The increasingly blurry lines between Germany’s medical and recreational cannabis markets are continuing to cause conflict among lawmakers and industry stakeholders ahead of the upcoming general election.
Bedrocan, one of Europe’s largest and longest-running suppliers of pharmaceutical and medical cannabis, has announced plans to commercialise a new high-CBD strain of cannabis, Bedrolina.
LONG-ESTABLISHED European cannabis company Bedrocan has re-entered the Canadian medical cannabis market following the purchase of a facility in Toronto.
Bedrocan, which for years has only supported external researchers financially, today announced the launching of its own Clinical Research Unit to conduct research into the effects of the cannabis products it produces on behalf of the Dutch government.
THE Department of Health & Social Care (DHSC) has announced that emergency measures to ensure supplies of childrens’ epilepsy cannabis medication remain accessible in the UK will be extended for another three months.
DANISH patients will be able to access medical cannabis for another four years after politicians agreed to extend a nationwide trial.
